• Ziprasidone–GOT1 Reprogramming in Pancreatic Cancer

  2026-08-19

  The 2022 Journal of Molecular Medicine study identifies ziprasidone as a non-competitive inhibitor of GOT1 and connects GOT1 inhibition with glutamine-metabolism disruption, redox imbalance, and reduced pancreatic ductal adenocarcinoma growth. Its combination of enzyme kinetics, cellular assays, metabolomics, genetic perturbation, and xenograft validation provides a mechanistic framework for evaluating GOT1 as a metabolic target, while leaving questions about selectivity, pharmacology, and clinical translation.

• Gap19: Cx43 Hemichannel Selectivity for Translation

  2026-08-19

  Gap19 is a selective connexin 43 hemichannel blocker that helps translational researchers separate pathological Cx43 hemichannel signaling from gap junction communication. This article connects astrocyte ATP release, neuroprotection in cerebral ischemia, Cx43/NF-κB-linked macrophage activation, and JAK2/STAT3 pathway modulation into a practical framework for stroke and ischemia/reperfusion injury research.

• AICAR: AMPK Activation for Metabolic Research

  2026-08-18

  AICAR is a cell-permeable AMPK activator used to study energy metabolism regulation, inflammatory signaling, and cellular stress responses. Its strongest role is as a preclinical pathway tool, not as a proven treatment for metabolic or inflammatory disease.

• Polymyxin B Workflows for CRE Research

  2026-08-18

  Polymyxin B supports more than antimicrobial screening: it can connect membrane-killing assays with carbapenem-resistant Enterobacter cloacae surveillance and immune-cell studies. This workflow shows how to use Polymyxin B sulfate for phenotype–genotype comparisons, sepsis and bacteremia models, and dendritic cell maturation assays while avoiding common interpretation errors.

• β-Amanitin Workflows for Transcription Research

  2026-08-17

  β-Amanitin provides a mechanistically defined way to interrogate RNA polymerase II activity, mRNA synthesis, and downstream protein expression. The same reference standard can also support amatoxin assay development, including the dual-target fluorescent workflow reported for mushroom samples.

• PPACK Dihydrochloride in Platelet Assays

  2026-08-17

  PPACK Dihydrochloride provides irreversible, high-affinity thrombin blockade for separating thrombin-dependent effects from receptor-specific platelet signaling. This guide turns that chemistry into practical workflows for thrombin inhibition assays, platelet aggregation inhibition, and blood coagulation research, with assay-design and troubleshooting guidance.

• LLY507 for Reliable SMYD2 Cell Assays

  2026-08-16

  LLY507 (SKU B6119) supports mechanism-aware viability, proliferation, and cytotoxicity workflows by combining high biochemical potency with documented SMYD2 selectivity and practical solvent guidance. This scenario-based guide explains formulation control, dose-response design, apoptosis assay interpretation, and vendor-selection considerations for cancer and fibrosis research.

• Lyotropic Coil–Bottlebrush Diblocks in Ionic Liquids

  2026-08-15

  Rodriguez, Mahanthappa, and Lodge examine how coil-block-bottlebrush diblock copolymers self-assemble in alkylimidazolium-based ionic liquids. Their central finding is that, despite substantial changes in solvent selectivity with ionic-liquid alkyl-chain length, the observed lyotropic phase behavior depends only weakly on ionic-liquid identity, suggesting a more flexible route to complex nanostructures.

• SmD2 Acetylation Links Splicing to PARP Sensitivity

  2026-08-15

  This 2024 Nature Communications study identifies the spliceosomal core protein SmD2 as a regulator of BRCA1/FANC cassette exons, DNA damage repair, and PARP inhibitor sensitivity in hepatocellular carcinoma. It further defines a p300–HDAC2 acetylation axis controlling SmD2 stability and supports combined HDAC and PARP inhibition as a strategy for HCC models.

• Frizzled5 Couples Cholesterol to Wnt Signaling in PDAC

  2026-08-14

  The reference study identifies Frizzled5 as a cholesterol-responsive Wnt receptor that links lipid metabolism to receptor palmitoylation, membrane trafficking, and β-catenin signaling in pancreatic ductal adenocarcinoma. Its findings explain how cholesterol can support Wnt-dependent tumor growth and provide a mechanistic basis for testing oxysterol-mediated disruption of this pathway.

• Clasto-Lactacystin β-lactone in RIPK3 Assays

  2026-08-13

  Clasto-Lactacystin β-lactone provides a mechanistically sharp way to test proteasome dependence in RIPK3 degradation and necroptosis studies. This article translates viral immune-evasion findings into rigorous proteasome inhibition assay design while clarifying controls, handling, and interpretation limits.

• L1023 Anti-Cancer Compound Library Workflow

  2026-08-13

  Build biomarker-led cancer screens around 1,164 pathway-focused compounds, from primary viability profiling to PLAC1-informed validation. The pre-dissolved format supports reproducible high-throughput screening while enabling orthogonal assays for kinase, apoptosis, and mTOR signaling pathway hypotheses.

• Hoechst 33258 for pH-Disrupted Tumor Assays

  2026-08-13

  Hoechst 33258 is a bis-benzimide DNA stain that can anchor nuclear and cell-cycle measurements in tumor models with disrupted pH homeostasis. This guide explains its binding chemistry, spectral behavior, assay controls, and how to interpret fluorescence alongside findings from a recent chemo-immunotherapy study.

• AMPK, ULK1, and Energy Stress in Autophagy

  2026-08-12

  The Nature Communications study redefines AMPK as a context-dependent regulator that suppresses ULK1-driven autophagy initiation during severe energy stress while preserving the autophagy machinery for recovery. Its findings distinguish short-term autophagy induction from long-term maintenance of autophagic competence, providing a more precise framework for interpreting metabolic stress experiments.

• Protease Inhibitor Cocktail for Plant Protein Workflows

  2026-08-12

  Protect unstable plant proteins with broad-spectrum inhibition in an EDTA-free, DMSO-based format designed for rapid extract handling. The workflow is especially useful for comparing STOP1 and STAR1 abundance, protein interactions, and phosphorylation-sensitive signals in plant stress studies.

461 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page